{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:07:40Z","timestamp":1788476860001,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.vaccine.2016.09.047","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:45:41Z","timestamp":1477529141000},"page":"5975-5983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Host immunity to  Mycobacterium tuberculosis  and risk of tuberculosis: A longitudinal study among Greenlanders"],"prefix":"10.1016","volume":"34","author":[{"given":"Sascha Wilk","family":"Michelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolette","family":"Soborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else Marie","family":"Agger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Jorge","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soren Tetens","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian Florian","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wohlfahrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.09.047_b0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010\u201350: cure, care, and social development","volume":"375","author":"L\u00f6nnroth","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.09.047_b0010","unstructured":"Sixty-seventh world health assembly. Global strategy and targets for tuberculosis prevention, care and control after 2015 2015;1:1\u201323."},{"key":"10.1016\/j.vaccine.2016.09.047_b0015","unstructured":"WHO. Global tuberculosis report; 2014."},{"key":"10.1016\/j.vaccine.2016.09.047_b0020","unstructured":"Tuberculosis Vaccine Initiative (TBVI) n.d. <http:\/\/www.tbvi.eu\/>."},{"key":"10.1016\/j.vaccine.2016.09.047_b0025","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.4049\/jimmunol.1202281","article-title":"Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell response","volume":"189","author":"Gideon","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.vaccine.2010.10.022","article-title":"Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease","volume":"29","author":"Govender","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.09.047_b0035","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1462-5822.2009.01325.x","article-title":"Hypoxia: a window into Mycobacterium tuberculosis latency","volume":"11","author":"Rustad","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.09.047_b0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/CVI.13.2.179-186.2006","article-title":"Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis","volume":"13","author":"Demissie","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0050","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.1201593","article-title":"An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection","volume":"190","author":"Commandeur","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0055","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.09.047_b0060","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","article-title":"Scaling up interventions to achieve global tuberculosis control: progress and new developments","volume":"379","author":"Raviglione","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.09.047_b0065","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1128\/IAI.00457-09","article-title":"Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria","volume":"77","author":"Lin","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.09.047_b0070","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/thoraxjnl-2014-205688","article-title":"The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland","volume":"69","author":"Michelsen","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2016.09.047_b0075","unstructured":"The National Board of Health in Greenland. National TB strategy 2012\u20132016; 2012."},{"key":"10.1016\/j.vaccine.2016.09.047_b0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/00039896.1968.10665273","article-title":"Contributions of northern populations to the understanding of tuberculin sensitivity","volume":"17","author":"Edwards","year":"1968","journal-title":"Arch Environ Health"},{"key":"10.1016\/j.vaccine.2016.09.047_b0085","first-page":"161","article-title":"A comparison in the United States of America of two tuberculins, Ppd-S and Rt 23","volume":"31","author":"Comstock","year":"1964","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.09.047_b0090","unstructured":"Statistics Greenland. Statistikbanken; 2015. <http:\/\/www.stat.gl\/default.asp?lang=da>."},{"key":"10.1016\/j.vaccine.2016.09.047_b0095","first-page":"441","article-title":"The Danish civil registration system. A cohort of eight million persons","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.vaccine.2016.09.047_b0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.09.047_b0105","unstructured":"Cellestis a QIAGEN Company. QuantiFERON\u00ae-TB Gold (QFT\u00ae) ELISA Package Insert; 2013. p. 1\u201336."},{"key":"10.1016\/j.vaccine.2016.09.047_b0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1600-0463.2009.02458.x","article-title":"Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development","volume":"117","author":"Dietrich","year":"2009","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2016.09.047_b0115","article-title":"Immune responses to latent tuberculosis antigen Rv2659c in Chinese populations","author":"Bai","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2016.09.047_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10096-015-2335-8","article-title":"Mycobacterium tuberculosis dormancy-associated antigen of Rv2660c induces stronger immune response in latent Mycobacterium tuberculosis infection than that in active tuberculosis in a Chinese population","author":"He","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.047_b0125","doi-asserted-by":"crossref","first-page":"e1001237","DOI":"10.1371\/journal.ppat.1001237","article-title":"Hypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccines","volume":"6","author":"Gideon","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.09.047_b0130","first-page":"75","article-title":"Assessment of T cell response to novel Mycobacterium tuberculosis synthetic overlapping peptides mixtures (Rv2659 and Rv2660) and ESAT-6 in Egyptian patients","volume":"21","author":"Salman","year":"2014","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tube.2007.10.001","article-title":"Comparison of IFN-\u03b3 responses to mycobacterial antigens as markers of response to BCG vaccination","volume":"88","author":"Weir","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2016.09.047_b0140","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00111-09","article-title":"Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa","volume":"16","author":"Black","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fmicb.2014.00517","article-title":"Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis","volume":"5","author":"Serra-Vidal","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1183\/09031936.00123314","article-title":"Effect of isoniazid on antigen-specific interferon-c secretion in latent tuberculosis","volume":"45","author":"Torres","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.09.047_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0074080","article-title":"Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa","volume":"8","author":"Sutherland","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.09.047_b0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00300-013-1410-9","article-title":"Bacterial diversity in Greenlandic soils as affected by potato cropping and inorganic versus organic fertilization","volume":"37","author":"Michelsen","year":"2014","journal-title":"Polar Biol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.09.047_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3007402","article-title":"TB or Not TB: that is no longer the question","volume":"5","author":"Modlin","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.09.047_b0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/imr.12258","article-title":"Immunology studies in non-human primate models of tuberculosis","volume":"264","author":"Flynn","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.09.047_b0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro3230","article-title":"In search of a new paradigm for protective immunity to TB","volume":"12","author":"Nunes-Alves","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0185","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.09.047_b0190","series-title":"Tuberculosis","first-page":"89","article-title":"Antigens for CD4 and CD8 T cells in tuberculosis","author":"Lindestram Arlehamn","year":"2015"},{"key":"10.1016\/j.vaccine.2016.09.047_b0195","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/MMBR.00021-14","article-title":"Tuberculosis vaccines and prevention of infection","volume":"78","author":"Hawn","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2016.09.047_b0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12274","article-title":"T cells and adaptive immunity to Mycobacterium tuberculosis in humans","volume":"264","author":"Jasenosky","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2016.09.047_b0205","first-page":"9","article-title":"Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset","author":"Lindestam Arlehamn","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.09.047_b0210","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/S0264-410X(00)00519-3","article-title":"Tuberculosis subunit vaccine development: on the role of interferon-gamma","volume":"19","author":"Agger","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.09.047_b0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri2960","article-title":"Immunological biomarkers of tuberculosis","volume":"11","author":"Walzl","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.09.047_b0220","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-\u03b3 horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2016.09.047_b0225","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12879-015-1201-8","article-title":"Effect of isoniazid preventive therapy on immune responses to Mycobacterium tuberculosis: an open label randomised, controlled, exploratory study","volume":"15","author":"Biraro","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.047_b0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1745-6673-1-7","article-title":"Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report","volume":"1","author":"Pai","year":"2006","journal-title":"J Occup Med Toxicol"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.09.047_b0235","article-title":"Abstract: deciphering tuberculosis dynamics in East Greenland: genomebased molecular epidemiology of Mycobacterium tuberculosis in a high-incidence area","volume":"19","author":"Bjorn-Mortensen","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2016.09.047_b0240","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.09.047_b0245","first-page":"dyv142","article-title":"Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review","author":"Kashangura","year":"2015","journal-title":"Int J Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16308726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16308726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T08:34:28Z","timestamp":1529915668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16308726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":49,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0264410X16308726"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}